| Control of endothelial cell polarity and sprouting angiogenesis by non-centrosomal microtubules M Martin, A Veloso, J Wu, EA Katrukha, A Akhmanova Elife 7, e33864, 2018 | 82 | 2018 |
| Therapeutic targeting of LCK tyrosine kinase and mTOR signaling in T-cell acute lymphoblastic leukemia S Laukkanen, A Veloso, C Yan, L Oksa, EJ Alpert, D Do, N Hyvärinen, ... Blood, The Journal of the American Society of Hematology 140 (17), 1891-1906, 2022 | 27 | 2022 |
| PRL3 enhances T-cell acute lymphoblastic leukemia growth through suppressing T-cell signaling pathways and apoptosis EG Garcia, A Veloso, ML Oliveira, JR Allen, S Loontiens, D Brunson, D Do, ... Leukemia 35 (3), 679-690, 2021 | 20 | 2021 |
| Single-cell imaging of T cell immunotherapy responses in vivo C Yan, Q Yang, S Zhang, DG Millar, EJ Alpert, D Do, A Veloso, ... Journal of Experimental Medicine 218 (10), e20210314, 2021 | 19 | 2021 |
| Mutant IL7R collaborates with MYC to induce T-cell acute lymphoblastic leukemia ML Oliveira, A Veloso, EG Garcia, S Iyer, C Pereira, VM Barreto, ... Leukemia 36 (6), 1533-1540, 2022 | 13 | 2022 |
| Dephosphorylation of HDAC4 by PP2A-Bδ unravels a new role for the HDAC4/MEF2 axis in myoblast fusion A Veloso, M Martin, J Bruyr, T O’Grady, C Deroanne, D Mottet, JC Twizere, ... Cell death & disease 10 (7), 512, 2019 | 13 | 2019 |
| CASZ1 upregulates PI3K-AKT-mTOR signaling and promotes T-cell acute lymphoblastic leukemia BA Cardoso, M Duque, A Gírio, R Fragoso, ML Oliveira, JR Allen, ... Haematologica, 2020 | 1 | 2020 |
| Dual targeting of EZH2 and Histone Deacetylases in hematological malignancies promotes transcriptional and metabolic deregulation leading to ferroptosis A Veloso, T Slegers, J Schoenaker, S Demeyer, S Van den Bergh, ... bioRxiv, 2024.03. 03.583195, 2024 | | 2024 |
| The cytoskeleton adaptor protein Sorbs1 controls the development of lymphatic and venous vessels in zebrafish A Veloso, A Bleuart, T Orban, J Bruyr, P Cabochette, RFV Germano, ... BMC Biology, 2024 | | 2024 |
| Targeting STAT5B in T-cell acute lymphoblastic leukemia A Veloso, J Cools Blood 142 (3), 215-217, 2023 | | 2023 |
| 3001–ABERRANT MYCN OVEREXPRESSION DRIVES ONCOGENIC HIJACKING OF EZH2 AS A TRANSCRIPTIONAL ACTIVATOR IN PERIPHERAL T CELL LYMPHOMA. MV Bempt, K Debackere, A Veloso, S Demeyer, T Slegers, Q Van Thillo, ... Experimental Hematology 124, S51, 2023 | | 2023 |
| Abstract A002: Dynamic single cell imaging of cancer stem cells and clonality in fusion-negative rhabdomyosarcoma T Eng, Y Wei, Q Qin, C Yan, Q Yang, A Veloso, K McCarthy, D Langenau Clinical Cancer Research 28 (18_Supplement), A002-A002, 2022 | | 2022 |
